Therapeutics Home
Home The TI Difference
About Us Drug Development
Contact Us Technology Assessment
News and Publications
News Publications
News and Publications quote

Selected Publications and Abstracts:

Lupo MP, Smith SR, Thomas JA, Murphy DK, Beddingfield FC. Effectiveness of Juvéderm Ultra Plus Dermal Filler in the Treatment of Severe Nasolabial Folds. Plast Reconstr Surg, 2008 Jan;121(1):289-297.


Narins RS, Brandt FS, Lorenc ZP, Maas CS, Monheit GD, Smith SR, McIntyre S. A Randomized, Multicenter Study of the Safety and Efficacy of Dermicol-P35 and Non-animal-Stabilized Hyaluronic Acid Gel for the Correction of Nasolabial Folds. Dermatol Surg, 2007 Dec;33:S213-S221.


Smith SR, Busso M, McClaren M, Bass LS. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds. Dermatol Surg, 2007 Dec;33:S112-S121.


Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB and the Phase IV ALA-PDT Actinic Keratosis Study Group. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Derm, 2006 Dec;155:1262-1269.


Smith S, Morhenn V, Webster G. The Characteristics and Utility of Solid Phase Porous Microspheres: A Review. J Drugs Dermatol, 2006 Nov;18(11):969-74.


Smith SR, Piacquadio DJ, Beger B, Littler C. Eflornithine Cream Combined with Laser Therapy in the Management of Unwanted Facial Hair Growth in Women: A Randomized Trial. Dermatol Surg, 2006 Oct;32:1237-43.


Ehrig T, Cockerell C, Piacquadio D, Dromgoole S. Actinic Keratoses and the Incidence of Occult Squamous Cell Carcinoma: A Clinical-Histopatologic Correlation. Dermatol Surg, 2006 Oct;32:1261-65.


Smith SR, Kempers S. A Study of 5.5% Benzoyl Peroxide Microsphere Cream Versus 6% Benzoyl Peroxide Gel in the Treatment of Acne Vulgaris. Cosmetic Derm, 2006 Aug;19(8):537-42.


Smith SR, Morhenn VB, Piacquadio DJ. Bilateral Comparison of the Efficacy and Tolerability of 3% Diclofenac Sodium Gel and 5% 5-Fluorouracil Cream in the Treatment of Actinic Keratoses of the Face and Scalp. J Drugs Dermatol, 2006 Feb;5(2):156-8.


Korman N, Moy R, Ling M, Matheson R, Smith S, McKane S, Lee JH. Dosing With 5% Imiquimod Cream 3 Times per Week for the Treatment of Actinic Keratosis. Arch Dermatol, 2005 Apr;141:467-73.

 

Torok HM, Jones T, Rich P, Smith S, Tschen E. Hydroquinone 4%, tretionoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12 month treatment of melasma. Cutis, 2005 Jan;75(1):57-62.

 

DiGiovanna JJ, Langman CB, Tschen EH, Jones T, Menter A, Lowe N, Eichenfield L, Hebert AA, Pariser D, Savin R, Smith SR, Jarratt M, Rodriguez D, Kang S, Shah LP, Wu E, Newhouse J, Pak J, Eberhardt DR, Bryce GF, McLane J, Ondovik M, Chin C, Khoo K-C, Rich P. Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne. J Am Acad Dermatol, 2004 Nov;51(5):709-17.

 

Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, Savin RC, Tharp MD. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol, 2004 Apr;50(4):541-43.

 

Piacquadio D, Chen D, Farber H, Fowler J, Glazer S, Goodman J, Hruza L, Jeffes E, Ling M, Phillips T, Rallis T, Scher R, Taylor C, Weinstein G  Photodynamic Therapy With Aminolevulinic Acid Topical Solution and Visible Blue Light in the Treatment of Multiple Actinic Keratoses of the Face and Scalp.  Arch Dermatol, 2004 Jan; Vol 140:41-46.

 

Smith S, Piacquadio D, Morhenn V, Atkin D, Fitzpatrick R  Short Incubation PDT versus 5-FU in Treating Actinic Keratoses.  J Drugs Dermatol 2003; 2(6):629-635.


Narins R, Brandt F, Leyden J, Lorenc P, Rubin M, Smith S A Randomized, Double-Blind, Multicenter Comparison of the Efficacy and Tolerability of Restylane Versus Zyplast for the Correction of Nasolabial Folds. Dermatological Surgery 2003 Jun;Vol 29:588-595.

Media Contact:

Denise Dwyer
Phone: 858.571.1800 x106
E-mail: media@therapeuticsinc.com


 
© 2008 Therapeutics Incorporated. Legal 9025 Balboa Avenue, Suite 100, San Diego, CA 92123 858-571-1800